News on Cytovax Biotechnologies Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Cytovax Biotechnologies Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 10:39:40 GMT en Osta Biotechnologies Announces $2.5 Million Private Placement Led by Sherbrooke Street Capitalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038920&HITNO=0&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038920&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038920&HITNO=0&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038920&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Osta Biotechnologies arranges $2.5-million placementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038371&HITNO=1&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038371&THISHREF=http://c.moreover.com/click/here.pl%3fz2537583645%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038371&HITNO=1&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038371&THISHREF=http://c.moreover.com/click/here.pl%3fz2537583645%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Osta Biotechnologies Announces $2.5 Million Private Placement Led by Sherbrooke Street Capitalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038539&HITNO=2&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038539&THISHREF=http://c.moreover.com/click/here.pl%3fz2537649628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038539&HITNO=2&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038539&THISHREF=http://c.moreover.com/click/here.pl%3fz2537649628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Osta Biotechnologies Announces $2.5 Million Private Placement Led by Sherbrooke Street Capitalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038296&HITNO=3&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038296&THISHREF=http://c.moreover.com/click/here.pl%3fz2537558273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038296&HITNO=3&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038296&THISHREF=http://c.moreover.com/click/here.pl%3fz2537558273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: LOCAL Commonwealth Biotechnologies subsidiary Mimotopes has signed a major contract with the Queensland Instithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035183&HITNO=4&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035183&THISHREF=http://c.moreover.com/click/here.pl%3fz2536151647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035183&HITNO=4&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035183&THISHREF=http://c.moreover.com/click/here.pl%3fz2536151647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioTechnologyNews.net: Epeius Biotechnologies Corporation-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030136&HITNO=5&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030136&THISHREF=http://c.moreover.com/click/here.pl%3fz2533459875%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030136&HITNO=5&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030136&THISHREF=http://c.moreover.com/click/here.pl%3fz2533459875%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Prometheus Makes Deal to Sell Skin and Kidney Cancer Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031275&HITNO=6&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031275&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031275&HITNO=6&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031275&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Diego Business Journal: Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Searchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028628&HITNO=7&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028628&THISHREF=http://c.moreover.com/click/here.pl%3fz2532789867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028628&HITNO=7&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028628&THISHREF=http://c.moreover.com/click/here.pl%3fz2532789867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Lifeline Biotechnologies Updates FDA Filing Preparation - Zibb.co...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018961&HITNO=8&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018961&THISHREF=http://c.moreover.com/click/here.pl%3fz2526016347%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018961&HITNO=8&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018961&THISHREF=http://c.moreover.com/click/here.pl%3fz2526016347%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Proneuron Biotechnologies, Inc.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021900&HITNO=9&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021900&THISHREF=http://c.moreover.com/click/here.pl%3fz2527400381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021900&HITNO=9&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021900&THISHREF=http://c.moreover.com/click/here.pl%3fz2527400381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Lifeline Biotechnologies Updates FDA Filing Preparationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019348&HITNO=10&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019348&THISHREF=http://c.moreover.com/click/here.pl%3fz2526236907%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019348&HITNO=10&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019348&THISHREF=http://c.moreover.com/click/here.pl%3fz2526236907%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com Singapore: Lifeline Biotechnologies Updates FDA Filing Preparationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018934&HITNO=11&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018934&THISHREF=http://c.moreover.com/click/here.pl%3fz2525998042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018934&HITNO=11&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018934&THISHREF=http://c.moreover.com/click/here.pl%3fz2525998042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Lifeline Biotechnologies Updates FDA Filing Preparationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019026&HITNO=12&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019026&THISHREF=http://c.moreover.com/click/here.pl%3fz2526075030%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019026&HITNO=12&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019026&THISHREF=http://c.moreover.com/click/here.pl%3fz2526075030%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: VaxGen shareholders reject merger planhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022634&HITNO=13&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022634&THISHREF=http://c.moreover.com/click/here.pl%3fz2527769806%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022634&HITNO=13&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022634&THISHREF=http://c.moreover.com/click/here.pl%3fz2527769806%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Business Journal: VaxGen shareholders reject merger planhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022572&HITNO=14&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022572&THISHREF=http://c.moreover.com/click/here.pl%3fz2527732355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022572&HITNO=14&MSIZE=318&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cytovax%20Biotechnologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022572&THISHREF=http://c.moreover.com/click/here.pl%3fz2527732355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Francisco Business Times: